IMAX CORPORATION REPORTS RECORD Q3 2023 RESULTS
- Global entertainment technology platform delivers strong Q3 year-over-year growth across all key financial metrics, including Revenue (+51%), Gross Margin (+98%) and Adjusted EBITDA (+174%)(1)
- Network growth accelerates while system signings climb to 120 to-date — more than double what the Company delivered in all of 2022 (47)
- Q3 marks the Company's second highest grossing quarter of all time at the global IMAX box office
- Box office strength drives significant operating leverage, delivering in the third quarter
$12 million in Net Income, Adjusted EPS(1) of$0.35 , record Adjusted EBITDA(1) of$45 million and Adjusted EBITDA Margin(1) of 47% - Robust cash flow generation continues, with cash from operations of
$55 million through nine months, compared with$0.5 million for the same period in 2022
"IMAX financial results for the third quarter are spectacular by any measure — versus budget, versus our historical performance and in the context of a highly dynamic business environment for media and entertainment," said
"Our outsized performance with
"It is clear that IMAX is the preferred way to experience blockbuster entertainment globally, and our global footprint, differentiated technology, and asset-lite model have made us a consistent winner. As we enter the fourth quarter, we remain on track to deliver significant growth in system signings, installations, and Adjusted EBITDA for the full year and one of the best years in our history at the global box office."
(1) |
Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts. |
Third Quarter Financial Highlights |
|||||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||||
|
|
||||||||||||||||||
In millions of |
2023 |
2022 |
YoY % |
2023 |
2022 |
YoY % |
|||||||||||||
Total Revenue |
$ |
103.9 |
$ |
68.8 |
51 % |
$ |
288.8 |
$ |
202.8 |
42 % |
|||||||||
Gross Margin |
$ |
62.7 |
$ |
31.7 |
98 % |
$ |
170.7 |
$ |
107.5 |
59 % |
|||||||||
Gross Margin (%) |
60 % |
46 % |
59 % |
53 % |
|||||||||||||||
Net Income (Loss)(2) |
$ |
12.0 |
$ |
(9.0) |
N/A |
$ |
22.8 |
$ |
(25.4) |
N/A |
|||||||||
Diluted Net Income (Loss) per share(2) |
$ |
0.22 |
$ |
(0.16) |
N/A |
$ |
0.41 |
$ |
(0.44) |
N/A |
|||||||||
Adjusted Net Income (Loss)(1)(2) |
$ |
19.4 |
$ |
(3.0) |
N/A |
$ |
42.8 |
$ |
(7.3) |
N/A |
|||||||||
Adjusted Net Income (Loss) per share(1)(2) |
$ |
0.35 |
$ |
(0.05) |
N/A |
$ |
0.77 |
$ |
(0.13) |
N/A |
|||||||||
Adjusted EBITDA per Credit Facility(1)(3) |
$ |
45.1 |
$ |
16.5 |
174 % |
$ |
105.1 |
$ |
56.7 |
85 % |
|||||||||
Adjusted EBITDA Margin (%)(1)(2) |
47 % |
26 % |
81 % |
39 % |
30 % |
30 % |
|||||||||||||
Weighted average shares outstanding (in millions): |
|||||||||||||||||||
Basic |
54.6 |
56.0 |
(3 %) |
54.4 |
57.3 |
(5 %) |
|||||||||||||
Diluted |
55.5 |
56.0 |
(1 %) |
55.3 |
57.3 |
(4 %) |
(1) |
Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts. |
(2) |
Attributable to common shareholders. |
(3) |
Adjusted EBITDA per Credit facility attributable to common shareholders. |
Third Quarter and September YTD Segment Results(1) |
|||||||||||||||||||||
Content Solutions |
Technology Products and Services |
||||||||||||||||||||
In millions of |
Revenue |
Gross |
Gross |
Revenue |
Gross |
Gross |
|||||||||||||||
3Q23 |
$ |
44.2 |
$ |
26.4 |
60 % |
$ |
56.2 |
$ |
33.8 |
60 % |
|||||||||||
3Q22 |
22.0 |
9.1 |
42 % |
45.5 |
21.8 |
48 % |
|||||||||||||||
% change |
101 % |
189 % |
23 % |
55 % |
|||||||||||||||||
YTD 3Q23 |
$ |
107.6 |
$ |
64.4 |
60 % |
$ |
171.8 |
$ |
100.1 |
58 % |
|||||||||||
YTD 3Q22 |
72.5 |
39.1 |
54 % |
$ |
126.3 |
65.9 |
52 % |
||||||||||||||
% change |
48 % |
65 % |
36 % |
52 % |
(1) |
Please refer to the Company's Form 10-Q for the period ended |
Content Solutions Segment
- Content Solutions revenues of
$44.2 million increased 101% year-over-year. Gross box office from IMAX locations in Q3 2023 of$347.1 million was up 96% from Q3 2022. Key contributors to third quarter box office performance included:Hollywood titles led by Oppenheimer with$180 million in IMAX GBO with significant contributions coming from Mission Impossible: Dead Reckoning Part 1 and Indiana Jones and the Dial of Destiny.- Local language titles led by the record setting Chinese title Creation of the Gods: Kingdom of Storms (
$32.3 million in IMAX GBO), with strong contributions coming from No More Bets, Lost in the Stars, and Jawan.
- Gross margin for Content Solutions was
$26.4 million (at a 60% margin) and increased 189% compared to the third quarter of the prior year period. This outsized growth was driven by the operating leverage in our business that resulted in very pronounced profit flow-through from box office.
Technology Products and Services Segment
- Technology Products and Services revenues and gross margin increased 23% year-over-year to
$56.2 million and 55% year-over-year to$33.8 million , respectively, which reflects growth in box office tied to rental revenues as well as a higher number of sale/hybrid installations. - During the third quarter the Company installed 30 systems compared to 17 systems in the third quarter of 2022. Of those, 16 systems were under sales and hybrid JRSA arrangements, compared to 9 systems in the prior year.
Operating Cash Flow and Liquidity
Net cash provided by operating activities for the nine months through September was
As of
In 2021, the Company issued
Share Count and Capital Return
The weighted average basic and diluted shares outstanding in the third quarter of 2023 were 54.6 million and 55.5 million, respectively, compared to 56.0 million for both in the third quarter of 2022, a decrease of 3% and 1%, respectively.
The Company repurchased 362,784 common shares at an average price of
On
Supplemental Materials
For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.
Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates on Tuesday of each week, although the Company may change this timing without notice. Results will be displayed with a few days lag.
The Company may post additional information on the Company's corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases,
Conference Call
The Company will host a conference call today at
About
IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe. Streaming technology company SSIMWAVE, an IMAX subsidiary, is a leader in AI-driven video quality solutions for media and entertainment companies.
IMAX is headquartered in
IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAXTM, IMAX LiveTM, IMAX Enhanced®, and SSIMWAVE® are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Instagram (https://www.instagram.com/imax), Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).
For additional information please contact:
Investors: |
Media: |
Forward-Looking Statements
This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, statements regarding the emergence of Cineworld from bankruptcy, as well as plans and references to the future success of
Primary Reporting Groups
The Company's Chief Executive Officer ("CEO") is its Chief Operating Decision Maker ("CODM"), as such term is defined under
In the first quarter of 2023, the Company revised its internal segment reporting, including the information provided to the CODM to assess segment performance and allocate resources. Accordingly, the Company has two reportable segments: (i) Content Solutions, which principally includes content enhancement and distribution services, previously included within the IMAX DMR, Film Distribution and Film Post-Production segments, and (ii) Technology Products and Services, which principally includes the sale, lease, and maintenance of IMAX Systems, previously included within the JRSA, IMAX Systems, IMAX Maintenance, and Other Theater Business segments. The Company's activities that do not meet the criteria to be considered a reportable segment are reported within All Other. Prior period comparatives have been revised to conform with the current period presentation.
The Company has the following reportable segments:
(i) |
Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services. |
(ii) |
Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses. |
Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.
IMAX Network and Backlog |
|||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||
System Signings: |
2023 |
2022 |
2023 |
2022 |
|||||||||||||
New IMAX Systems |
|||||||||||||||||
Sales and sales-type lease arrangements |
7 |
3 |
44 |
9 |
|||||||||||||
Hybrid JRSA |
— |
1 |
— |
3 |
|||||||||||||
Traditional JRSA |
7 |
7 |
32 |
9 |
|||||||||||||
Total new IMAX Systems |
14 |
11 |
76 |
21 |
|||||||||||||
Upgrades of IMAX systems |
6 |
4 |
18 |
14 |
|||||||||||||
Total IMAX System signings |
20 |
15 |
94 |
35 |
|||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||
System Installations: |
2023 |
2022 |
2023 |
2022 |
|||||||||||||
New IMAX Systems |
|||||||||||||||||
Sales and sales-type lease arrangements |
14 |
7 |
30 |
14 |
|||||||||||||
Hybrid JRSA |
— |
2 |
2 |
5 |
|||||||||||||
Traditional JRSA |
4 |
7 |
7 |
16 |
|||||||||||||
Total new IMAX Systems |
18 |
16 |
39 |
35 |
|||||||||||||
Upgrades of IMAX Systems |
12 |
1 |
20 |
5 |
|||||||||||||
Total IMAX System installations |
30 |
17 |
59 |
40 |
|||||||||||||
|
|||||||||||||||||
IMAX System Backlog: |
2023 |
2022 |
|||||||||||||||
Sales and sales-type lease arrangements |
192 |
170 |
|||||||||||||||
Hybrid JRSA |
107 |
127 |
|||||||||||||||
Traditional JRSA |
187 |
192 |
|||||||||||||||
Total IMAX System backlog |
486 |
489 |
|||||||||||||||
|
|||||||||||||||||
IMAX Network: |
2023 |
2022 |
|||||||||||||||
|
|||||||||||||||||
Sales and sales-type lease arrangements |
743 |
696 |
|||||||||||||||
Hybrid JRSA |
137 |
150 |
|||||||||||||||
Traditional JRSA |
771 |
776 |
|||||||||||||||
|
1,651 |
1,622 |
|||||||||||||||
|
12 |
12 |
|||||||||||||||
|
68 |
69 |
|||||||||||||||
Total IMAX network |
1,731 |
1,703 |
|
|||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||||
(In thousands of |
|||||||||||||||||
(Unaudited) |
|||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||
|
|
||||||||||||||||
2023 |
2022 |
2023 |
2022 |
||||||||||||||
Revenues |
|||||||||||||||||
Technology sales |
$ |
18,273 |
$ |
18,065 |
$ |
65,455 |
$ |
35,270 |
|||||||||
Image enhancement and maintenance services |
60,250 |
36,233 |
154,244 |
117,285 |
|||||||||||||
Technology rentals |
23,008 |
12,540 |
62,612 |
43,726 |
|||||||||||||
Finance income |
2,365 |
1,917 |
6,510 |
6,478 |
|||||||||||||
103,896 |
68,755 |
288,821 |
202,759 |
||||||||||||||
Costs and expenses applicable to revenues |
|||||||||||||||||
Technology sales |
7,948 |
10,061 |
28,951 |
20,264 |
|||||||||||||
Image enhancement and maintenance services |
26,646 |
20,563 |
69,470 |
56,259 |
|||||||||||||
Technology rentals |
6,587 |
6,430 |
19,747 |
18,728 |
|||||||||||||
41,181 |
37,054 |
118,168 |
95,251 |
||||||||||||||
Gross margin |
62,715 |
31,701 |
170,653 |
107,508 |
|||||||||||||
Selling, general and administrative expenses |
36,282 |
32,905 |
109,336 |
100,181 |
|||||||||||||
Research and development |
2,771 |
1,115 |
7,388 |
3,667 |
|||||||||||||
Amortization of intangible assets |
1,107 |
1,111 |
3,328 |
3,412 |
|||||||||||||
Credit loss expense, net |
523 |
808 |
1,589 |
8,149 |
|||||||||||||
Asset impairments |
— |
— |
— |
4,470 |
|||||||||||||
Executive transition costs |
— |
— |
1,353 |
— |
|||||||||||||
Income (loss) from operations |
22,032 |
(4,238) |
47,659 |
(12,371) |
|||||||||||||
Unrealized investment gains |
364 |
35 |
436 |
99 |
|||||||||||||
Retirement benefits non-service expense |
(77) |
(140) |
(232) |
(417) |
|||||||||||||
Interest income |
738 |
257 |
1,838 |
1,176 |
|||||||||||||
Interest expense |
(1,483) |
(1,323) |
(5,045) |
(4,354) |
|||||||||||||
Income (loss) before taxes |
21,574 |
(5,409) |
44,656 |
(15,867) |
|||||||||||||
Income tax expense |
(6,555) |
(2,348) |
(14,901) |
(8,091) |
|||||||||||||
Net income (loss) |
15,019 |
(7,757) |
29,755 |
(23,958) |
|||||||||||||
Less: net (income) loss attributable to non-controlling interests |
(3,029) |
(1,196) |
(6,960) |
(1,455) |
|||||||||||||
Net income (loss) attributable to common shareholders |
$ |
11,990 |
$ |
(8,953) |
$ |
22,795 |
$ |
(25,413) |
|||||||||
Net income (loss) per share attributable to common shareholders: |
|||||||||||||||||
Basic |
$ |
0.22 |
$ |
(0.16) |
$ |
0.42 |
$ |
(0.44) |
|||||||||
Diluted |
$ |
0.22 |
$ |
(0.16) |
$ |
0.41 |
$ |
(0.44) |
|||||||||
Weighted average shares outstanding (in thousands): |
|||||||||||||||||
Basic |
54,618 |
56,039 |
54,424 |
57,301 |
|||||||||||||
Diluted |
55,535 |
56,039 |
55,261 |
57,301 |
|||||||||||||
Additional Disclosure: |
|||||||||||||||||
Depreciation and amortization |
$ |
19,279 |
$ |
15,640 |
$ |
46,477 |
$ |
42,663 |
|||||||||
Amortization of deferred financing costs |
$ |
492 |
$ |
712 |
$ |
1,742 |
$ |
2,465 |
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(In thousands of |
||||||||
(Unaudited) |
||||||||
|
|
|||||||
2023 |
2022 |
|||||||
Assets |
||||||||
Cash and cash equivalents |
$ |
109,603 |
$ |
97,401 |
||||
Accounts receivable, net of allowance for credit losses |
135,962 |
136,142 |
||||||
Financing receivables, net of allowance for credit losses |
125,322 |
129,384 |
||||||
Variable consideration receivables, net of allowance for credit losses |
59,042 |
44,024 |
||||||
Inventories |
45,365 |
31,534 |
||||||
Prepaid expenses |
13,042 |
12,343 |
||||||
Film assets, net of accumulated amortization |
5,232 |
5,277 |
||||||
Property, plant and equipment, net of accumulated depreciation |
238,140 |
252,896 |
||||||
Investment in equity securities |
— |
1,035 |
||||||
Other assets |
20,119 |
15,665 |
||||||
Deferred income tax assets, net of valuation allowance |
11,961 |
9,900 |
||||||
|
52,815 |
52,815 |
||||||
Other intangible assets, net of accumulated amortization |
34,343 |
32,738 |
||||||
Total assets |
$ |
850,946 |
$ |
821,154 |
||||
Liabilities |
||||||||
Accounts payable |
$ |
37,699 |
$ |
25,237 |
||||
Accrued and other liabilities |
123,863 |
117,286 |
||||||
Deferred revenue |
66,272 |
70,940 |
||||||
Revolving credit facility borrowings, net of unamortized debt issuance costs |
23,903 |
36,111 |
||||||
Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs |
228,449 |
226,912 |
||||||
Deferred income tax liabilities |
13,349 |
14,900 |
||||||
Total liabilities |
493,535 |
491,386 |
||||||
Commitments, contingencies and guarantees |
||||||||
Non-controlling interests |
661 |
722 |
||||||
Shareholders' equity |
||||||||
Capital stock common shares — no par value. Authorized — unlimited number. |
||||||||
54,607,095 issued and outstanding ( |
390,097 |
376,715 |
||||||
Other equity |
179,970 |
185,678 |
||||||
Statutory surplus reserve |
3,932 |
3,932 |
||||||
Accumulated deficit |
(272,318) |
(293,124) |
||||||
Accumulated other comprehensive loss |
(14,637) |
(9,846) |
||||||
Total shareholders' equity attributable to common shareholders |
287,044 |
263,355 |
||||||
Non-controlling interests |
69,706 |
65,691 |
||||||
Total shareholders' equity |
356,750 |
329,046 |
||||||
Total liabilities and shareholders' equity |
$ |
850,946 |
$ |
821,154 |
|
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
(In thousands of |
||||||||
(Unaudited) |
||||||||
Nine Months Ended |
||||||||
|
||||||||
2023 |
2022 |
|||||||
Operating Activities |
||||||||
Net income (loss) |
$ |
29,755 |
$ |
(23,958) |
||||
Adjustments to reconcile net income (loss) to cash provided by operating activities: |
||||||||
Depreciation and amortization |
46,477 |
42,663 |
||||||
Amortization of deferred financing costs |
1,742 |
2,465 |
||||||
Credit loss expense, net |
1,589 |
8,149 |
||||||
Write-downs |
872 |
5,707 |
||||||
Deferred income tax benefit |
(3,724) |
(3,374) |
||||||
Share-based and other non-cash compensation |
17,830 |
19,510 |
||||||
Unrealized foreign currency exchange loss |
52 |
1,310 |
||||||
Unrealized investment gains |
(436) |
(99) |
||||||
Changes in assets and liabilities: |
||||||||
Accounts receivable |
(2,392) |
(18,050) |
||||||
Inventories |
(13,771) |
(10,131) |
||||||
Film assets |
(14,575) |
(14,174) |
||||||
Deferred revenue |
(4,670) |
(5,989) |
||||||
Changes in other operating assets and liabilities |
(4,141) |
(3,548) |
||||||
Net cash provided by operating activities |
54,608 |
481 |
||||||
Investing Activities |
||||||||
Purchase of property, plant and equipment |
(2,541) |
(5,248) |
||||||
Investment in equipment for joint revenue sharing arrangements |
(10,705) |
(14,543) |
||||||
Interest in film classified as a financial instrument |
— |
(4,731) |
||||||
Acquisition of other intangible assets |
(5,418) |
(3,246) |
||||||
Acquisition of SSIMWAVE, net of cash and cash equivalents acquired |
— |
(12,639) |
||||||
Net cash used in investing activities |
(18,664) |
(40,407) |
||||||
Financing Activities |
||||||||
Revolving credit facility borrowings |
31,032 |
4,890 |
||||||
Repayments of revolving credit facility borrowings |
(43,057) |
(3,600) |
||||||
Credit facility amendment fees paid |
— |
(2,277) |
||||||
Other borrowings |
315 |
— |
||||||
Repurchase of common shares |
(4,263) |
(53,581) |
||||||
Repurchase of common shares, IMAX China |
— |
(3,043) |
||||||
Taxes withheld and paid on employee stock awards vested |
(6,458) |
(3,393) |
||||||
Principal payment under finance lease obligations |
(480) |
(890) |
||||||
Dividends paid to non-controlling interests |
(1,438) |
(2,701) |
||||||
Net cash used in financing activities |
(24,349) |
(64,595) |
||||||
Effects of exchange rate changes on cash |
607 |
1,961 |
||||||
Increase (decrease) in cash and cash equivalents during period |
12,202 |
(102,560) |
||||||
Cash and cash equivalents, beginning of period |
97,401 |
189,711 |
||||||
Cash and cash equivalents, end of period |
$ |
109,603 |
$ |
87,151 |
Segment Revenue and Gross Margin |
|||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||
|
|
||||||||||||||||
(In thousands of |
2023 |
2022 |
2023 |
2022 |
|||||||||||||
Revenue |
|||||||||||||||||
Content Solutions |
$ |
44,214 |
$ |
21,967 |
$ |
107,605 |
$ |
72,499 |
|||||||||
Technology Products and Services |
56,169 |
45,542 |
171,813 |
126,262 |
|||||||||||||
Sub-total for reportable segments |
100,383 |
67,509 |
279,418 |
198,761 |
|||||||||||||
All Other(1) |
3,513 |
1,246 |
9,403 |
3,998 |
|||||||||||||
Total |
$ |
103,896 |
$ |
68,755 |
$ |
288,821 |
$ |
202,759 |
|||||||||
Gross Margin |
|||||||||||||||||
Content Solutions |
$ |
26,407 |
$ |
9,140 |
$ |
64,397 |
$ |
39,121 |
|||||||||
Technology Products and Services |
33,761 |
21,752 |
100,066 |
65,875 |
|||||||||||||
Sub-total for reportable segments |
60,168 |
30,892 |
164,463 |
104,996 |
|||||||||||||
All Other(1) |
2,547 |
809 |
6,190 |
2,512 |
|||||||||||||
Total |
$ |
62,715 |
$ |
31,701 |
$ |
170,653 |
$ |
107,508 |
(1) |
All Other includes the results from the Company's streaming and consumer technology business, as well as other ancillary activities. |
NON-GAAP FINANCIAL MEASURES
(in thousands of
In this release, the Company presents adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company's performance, which are not recognized under
The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income (loss) attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.
A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share are presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.
In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as well as "Adjusted EBITDA per Credit Facility," as defined in the Company's Credit Agreement. As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements, when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.
EBITDA is defined as net income or loss excluding (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; (iv) executive transition costs; and (v) write-downs, net of recoveries, including asset impairments and credit loss expense.
A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.
In this release, the Company also presents free cash flow, which is not recognized under
These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.
Adjusted EBITDA per Credit Facility |
||||||||||||||||||||||||
For the Three Months Ended |
For the Three Months Ended |
|||||||||||||||||||||||
Attributable to |
Attributable to |
|||||||||||||||||||||||
Non-controlling |
Less: |
Non-controlling |
Less: |
|||||||||||||||||||||
Interests and |
Attributable to |
Attributable to |
Interests and |
Attributable to |
Attributable to |
|||||||||||||||||||
Common |
Non-controlling |
Common |
Common |
Non-controlling |
Common |
|||||||||||||||||||
(In thousands of |
Shareholders |
Interests |
Shareholders |
Shareholders |
Interests |
Shareholders |
||||||||||||||||||
Reported net income (loss) |
$ |
15,019 |
$ |
3,029 |
$ |
11,990 |
$ |
(7,757) |
$ |
1,196 |
$ |
(8,953) |
||||||||||||
Add (subtract): |
||||||||||||||||||||||||
Income tax expense |
6,555 |
1,041 |
5,514 |
2,348 |
(22) |
2,370 |
||||||||||||||||||
Interest expense, net of interest income |
253 |
(145) |
398 |
354 |
(39) |
393 |
||||||||||||||||||
Depreciation and amortization, including film asset |
19,279 |
1,304 |
17,975 |
15,640 |
1,214 |
14,426 |
||||||||||||||||||
Amortization of deferred financing costs(1) |
492 |
— |
492 |
712 |
— |
712 |
||||||||||||||||||
EBITDA |
$ |
41,598 |
$ |
5,229 |
$ |
36,369 |
$ |
11,297 |
$ |
2,349 |
$ |
8,948 |
||||||||||||
Share-based and other non-cash compensation |
5,297 |
155 |
5,142 |
5,544 |
(27) |
5,571 |
||||||||||||||||||
Unrealized investment gains |
(364) |
(93) |
(271) |
(35) |
— |
(35) |
||||||||||||||||||
Transaction-related expenses |
3,086 |
— |
3,086 |
955 |
— |
955 |
||||||||||||||||||
Write-downs, including asset impairments and credit |
921 |
164 |
757 |
1,083 |
66 |
1,017 |
||||||||||||||||||
Adjusted EBITDA per Credit Facility |
$ |
50,538 |
$ |
5,455 |
$ |
45,083 |
$ |
18,844 |
$ |
2,388 |
$ |
16,456 |
||||||||||||
Revenues attributable to common shareholders(2) |
$ |
103,896 |
$ |
8,028 |
$ |
95,868 |
$ |
68,755 |
$ |
4,257 |
$ |
64,498 |
||||||||||||
Adjusted EBITDA margin attributable to common |
49 % |
68 % |
47 % |
27 % |
56 % |
26 % |
||||||||||||||||||
For the Twelve Months Ended |
For the Twelve Months Ended |
|||||||||||||||||||||||
Attributable to |
Attributable to |
|||||||||||||||||||||||
Non-controlling |
Less: |
Non-controlling |
Less: |
|||||||||||||||||||||
Interests and |
Attributable to |
Attributable to |
Interests and |
Attributable to |
Attributable to |
|||||||||||||||||||
Common |
Non-controlling |
Common |
Common |
Non-controlling |
Common |
|||||||||||||||||||
(In thousands of |
Shareholders |
Interests |
Shareholders |
Shareholders |
Interests |
Shareholders |
||||||||||||||||||
Reported net income (loss) |
$ |
33,836 |
$ |
8,428 |
$ |
25,408 |
$ |
(10,579) |
$ |
4,734 |
$ |
(15,313) |
||||||||||||
Add (subtract): |
||||||||||||||||||||||||
Income tax expense |
16,917 |
2,658 |
14,259 |
19,239 |
2,027 |
17,212 |
||||||||||||||||||
Interest expense, net of interest income |
2,024 |
(286) |
2,310 |
970 |
(327) |
1,297 |
||||||||||||||||||
Depreciation and amortization, including film asset |
60,475 |
5,260 |
55,215 |
58,175 |
5,056 |
53,119 |
||||||||||||||||||
Amortization of deferred financing costs(1) |
2,454 |
— |
2,454 |
3,229 |
— |
3,229 |
||||||||||||||||||
EBITDA |
$ |
115,706 |
$ |
16,060 |
$ |
99,646 |
$ |
71,034 |
$ |
11,490 |
$ |
59,544 |
||||||||||||
Share-based and other non-cash compensation |
25,893 |
835 |
25,058 |
27,031 |
845 |
26,186 |
||||||||||||||||||
Unrealized investment gains |
(407) |
(93) |
(314) |
(128) |
— |
(128) |
||||||||||||||||||
Transaction-related expenses |
3,408 |
— |
3,408 |
955 |
— |
955 |
||||||||||||||||||
Write-downs, including asset impairments and credit |
4,328 |
561 |
3,767 |
15,675 |
1,538 |
14,137 |
||||||||||||||||||
Executive transition costs |
1,353 |
— |
1,353 |
— |
— |
— |
||||||||||||||||||
Adjusted EBITDA per Credit Facility |
$ |
150,281 |
$ |
17,363 |
$ |
132,918 |
$ |
114,567 |
$ |
13,873 |
$ |
100,694 |
||||||||||||
Revenues attributable to common shareholders(2) |
$ |
386,867 |
$ |
28,260 |
$ |
358,607 |
$ |
311,331 |
$ |
24,347 |
$ |
286,984 |
||||||||||||
Adjusted EBITDA margin attributable to common |
39 % |
61 % |
37 % |
37 % |
57 % |
35 % |
(1) |
The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations. |
|||||
(2) |
Revenues attributable to common shareholders calculated as follows: |
|||||
Three months ended |
Three months ended |
Twelve months ended |
Twelve months ended |
|||||||||||||||||||||||||||||||||||
(In thousands of |
|
|
|
|
||||||||||||||||||||||||||||||||||
Total revenues |
$ |
103,896 |
$ |
68,755 |
$ |
386,867 |
$ |
311,331 |
||||||||||||||||||||||||||||||
|
$ |
28,297 |
$ |
14,889 |
$ |
99,703 |
$ |
84,769 |
||||||||||||||||||||||||||||||
Non-controlling interest ownership percentage(3) |
28.37 % |
28.59 % |
28.34 % |
28.72 % |
||||||||||||||||||||||||||||||||||
Deduction for non-controlling interest share of |
(8,028) |
(4,257) |
(28,260) |
(24,347) |
||||||||||||||||||||||||||||||||||
Revenues attributable to common shareholders |
$ |
95,868 |
$ |
64,498 |
$ |
358,607 |
$ |
286,984 |
(3) |
Weighted average ownership percentage for change in non-controlling interest share. |
Adjusted Net Income (Loss) Attributable to Common Shareholders and Adjusted Net Income (Loss) Per Share |
||||||||||||||||
Three Months Ended |
||||||||||||||||
2023 |
2022 |
|||||||||||||||
(In thousands of |
Net Income |
Per Share |
Net Loss |
Per Share |
||||||||||||
Net income (loss) attributable to common shareholders |
$ |
11,990 |
$ |
0.22 |
$ |
(8,953) |
$ |
(0.16) |
||||||||
Adjustments(1): |
||||||||||||||||
Share-based compensation |
5,063 |
0.09 |
5,431 |
0.10 |
||||||||||||
COVID-19 government relief benefits, net |
— |
— |
(212) |
— |
||||||||||||
Unrealized investment gains |
(454) |
(0.01) |
(34) |
— |
||||||||||||
Transaction-related expenses |
3,086 |
0.06 |
955 |
0.02 |
||||||||||||
Tax impact on items listed above |
(275) |
— |
(214) |
— |
||||||||||||
Adjusted net income (loss)(1) |
$ |
19,410 |
$ |
0.35 |
$ |
(3,027) |
$ |
(0.05) |
||||||||
Weighted average shares outstanding — basic |
54,618 |
56,039 |
||||||||||||||
Weighted average shares outstanding — diluted |
55,535 |
56,039 |
||||||||||||||
Nine Months Ended |
||||||||||||||||
2023 |
2022 |
|||||||||||||||
(In thousands of |
Net Income |
Per Share |
Net Loss |
Per Share |
||||||||||||
Net income (loss) attributable to common shareholders |
$ |
22,795 |
$ |
0.41 |
$ |
(25,413) |
$ |
(0.44) |
||||||||
Adjustments(1): |
||||||||||||||||
Stock-based compensation |
17,110 |
0.31 |
18,651 |
0.33 |
||||||||||||
COVID-19 government relief benefits, net |
— |
— |
(373) |
(0.01) |
||||||||||||
Unrealized investment gains |
(526) |
(0.01) |
(98) |
— |
||||||||||||
Transaction-related expenses |
3,242 |
0.06 |
955 |
0.02 |
||||||||||||
Executive transition costs |
1,353 |
0.02 |
— |
— |
||||||||||||
Tax impact on items listed above |
(1,184) |
(0.02) |
(1,071) |
(0.02) |
||||||||||||
Adjusted net income (loss)(1) |
$ |
42,790 |
$ |
0.77 |
$ |
(7,349) |
$ |
(0.13) |
||||||||
Weighted average shares outstanding — basic |
54,424 |
57,301 |
||||||||||||||
Weighted average shares outstanding — diluted |
55,261 |
57,301 |
(1) |
Reflects amounts attributable to common shareholders. |
Free Cash Flow |
|||||||||
Nine Months Ended |
Nine Months Ended |
||||||||
(In thousands of |
|
|
|||||||
Net cash provided by operating activities |
$ |
54,608 |
$ |
481 |
|||||
Net cash used in capital expenditures |
(18,664) |
(23,037) |
|||||||
Free cash flow |
$ |
35,944 |
$ |
(22,556) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/imax-corporation-reports-record-q3-2023-results-301966689.html
SOURCE